Paper36934848
PPARγ inhibits small airway remodeling through mediating the polarization homeostasis of alveolar macrophages in COPD.
He S and 9 others. Clin Immunol, 2023. Cited by 35 papers, by iCite.
Cite this record
ConductScience Library. PPARγ inhibits small airway remodeling through mediating the polarization homeostasis of alveolar macrophages in COPD. Papers, record 36934848. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36934848
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- PPARγ inhibits small airway remodeling through mediating the polarization homeostasis of alveolar macrophages in COPD.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Macrophages, Alveolar | Major topic |
| Pulmonary Disease, Chronic Obstructive | Major topic |
| Mice | |
| Animals | |
| PPAR gamma | |
| Airway Remodeling | |
| Lipopolysaccharides | |
| Homeostasis |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42846262 | The role of the gut-lung axis in persistent inflammation and disease progression in chronic obstructive pulmonary disease: mechanistic evidence and therapeutic implications. | Front Immunol | 2026 | https://conductscience.org/library/papers/42846262 | PubMed |
| 42602634 | UHPLC -Q-Orbitrap HRMS Integrated with Network Pharmacology Reveals the Anti-COPD Mechanism of Jianzhong Peiyuan Decoction and Functional Validation of Core Component Luteolin. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42602634 | PubMed |
| 42000611 | Epithelial cells in chronic obstructive pulmonary disease exacerbations: Targets for lung repair. | Pharmacol Rev | 2026 | https://conductscience.org/library/papers/42000611 | PubMed |
| 41856010 | Regenerative therapeutics for chronic obstructive pulmonary disease. | Pharmacol Rev | 2026 | https://conductscience.org/library/papers/41856010 | PubMed |
| 41811672 | Andrographolide Alleviates Inflammation in Chronic Obstructive Pulmonary Disease by Inhibiting Alveolar Macrophage Pyroptosis Through the JNK/NLRP3 Pathway. | Cell Biochem Biophys | 2026 | https://conductscience.org/library/papers/41811672 | PubMed |
| 41588511 | RANKL promotes airway inflammation via pro-inflammatory alveolar macrophage activation in COPD. | Respir Res | 2026 | https://conductscience.org/library/papers/41588511 | PubMed |
| 41409289 | From metabolic alterations to chronic inflammation: mechanisms and immunoregulation of metabolic reprogramming in COPD. | Front Immunol | 2025 | https://conductscience.org/library/papers/41409289 | PubMed |
| 41383596 | Metabolic reprogramming of macrophages in chronic obstructive pulmonary disease. | Front Immunol | 2025 | https://conductscience.org/library/papers/41383596 | PubMed |
| 41373005 | The cellular triangle in bronchiectasis: the interplay network and regulatory mechanisms of neutrophils, macrophages, and epithelial cells. | Eur J Med Res | 2025 | https://conductscience.org/library/papers/41373005 | PubMed |
| 41229861 | A bibliometric analysis of macrophages associated with chronic obstructive pulmonary disease from 2005 to 2025. | J Thorac Dis | 2025 | https://conductscience.org/library/papers/41229861 | PubMed |
| 41015566 | [Therapeutic effects of natural products on animal models of chronic obstructive pulmonary disease]. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2025 | https://conductscience.org/library/papers/41015566 | PubMed |
| 40836215 | Correlation between gut microbiota and metabolomics under intermittent hypoxic conditions. | BMC Microbiol | 2025 | https://conductscience.org/library/papers/40836215 | PubMed |
| 40792306 | Airway remodeling in chronic obstructive pulmonary disease: characteristics and opportunities. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40792306 | PubMed |
| 40786749 | Breath and Bottle: Evaluating Pharmacotherapy for Alcohol Use Disorder on COPD Exacerbation Outcomes. | Int J Chron Obstruct Pulmon Dis | 2025 | https://conductscience.org/library/papers/40786749 | PubMed |
| 40655182 | The Crucial Role of the PPAR Signaling Pathway in the Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease: An Analysis of Gene Expression and Macrophage Polarization. | Int J Chron Obstruct Pulmon Dis | 2025 | https://conductscience.org/library/papers/40655182 | PubMed |
| 40214820 | Based exploration of the diagnostic value of oxidative stress-related key genes in chronic obstructive pulmonary disease. | Cell Biol Toxicol | 2025 | https://conductscience.org/library/papers/40214820 | PubMed |
| 39781522 | Advances on the Role of Lung Macrophages in the Pathogenesis of Chronic Obstructive Pulmonary Disease in the Era of Single-Cell Genomics. | Int J Med Sci | 2025 | https://conductscience.org/library/papers/39781522 | PubMed |
| 39751854 | Mitochondrial Quality Control: A New Perspective in Skeletal Muscle Dysfunction of Chronic Obstructive Pulmonary Disease. | Aging Dis | 2024 | https://conductscience.org/library/papers/39751854 | PubMed |
| 39482714 | Significance of serum lncRNA XIST in chronic obstructive pulmonary disease and its progression to pulmonary heart disease. | BMC Pulm Med | 2024 | https://conductscience.org/library/papers/39482714 | PubMed |
| 39356034 | Targeting Immunoproteasome in Polarized Macrophages Ameliorates Experimental Emphysema Via Activating NRF1/2-P62 Axis and Suppressing IRF4 Transcription. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/39356034 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PPARG | 5468 | PubTator's text mining | https://conductscience.org/library/genes/5468 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36934848
GET https://conductscience.org/api/papers/v1/36934848/cited_by?page=2